2005
DOI: 10.1016/j.bbrc.2005.05.035
|View full text |Cite
|
Sign up to set email alerts
|

α-Lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

6
124
2
6

Year Published

2006
2006
2017
2017

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 204 publications
(138 citation statements)
references
References 41 publications
6
124
2
6
Order By: Relevance
“…Second, AMPK activation by t-RVT definitely potentiated the insulin-induced Akt activation ( Figure 4B), leading to improvement of insulin sensitivity. Quite similar to our results, a couple of recent studies demonstrated that -lipoic acid as well as metformin has been reported to improve insulin sensitivity by activating AMPK (Kumar and Dey, 2002;Lee et al, 2005). Despite many efforts, the mechanism by which AMPK increase insulin sensitivity remains almost unknown.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…Second, AMPK activation by t-RVT definitely potentiated the insulin-induced Akt activation ( Figure 4B), leading to improvement of insulin sensitivity. Quite similar to our results, a couple of recent studies demonstrated that -lipoic acid as well as metformin has been reported to improve insulin sensitivity by activating AMPK (Kumar and Dey, 2002;Lee et al, 2005). Despite many efforts, the mechanism by which AMPK increase insulin sensitivity remains almost unknown.…”
Section: Discussionsupporting
confidence: 90%
“…Thiazolindinediones (TZDs), another antidiabetic drugs which are specific ligands for peroxisome proliferator-activated receptor-, has also been shown to improve insulin sensitivity by activating AMPK . In addition, antiobesitic effect of leptin, adiponectin, and -lipoic acid is mediated by AMPK Yamauchi et al, 2002;Lee et al, 2005). Therefore, AMPK is thought to be a novel therapeutic target to reduce blood glucose levels in type 2 diabetes mellitus.…”
Section: Introductionmentioning
confidence: 99%
“…All secretion and total insulin data were normalised to total DNA and are expressed as means±SE. *p<0.05; **p<0.01; ***p<0.001 compared with controls α-LA acted as an insulin sensitiser in skeletal muscle [38], and prevented endothelial cell dysfunction in obese rats [39], effects shown to be attributable to AMPK activation. Thus, it is likely that AMPK is responsible for many of the diverse antidiabetic effects of this compound.…”
Section: Discussionmentioning
confidence: 91%
“…Dysfunction of AMPK activity may lead to metabolic syndrome. There is correlation between the low activation state of AMPK with metabolic disorders associated with insulin resistance and obesity (23,24). AMPK activity is also suppressed in muscle and liver by sustained hyperglycemia (25).…”
Section: Discussionmentioning
confidence: 99%